IDEAYA Biosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IDYA | RCUS | IOVA | IMCR | ERAS | IMNM | |
|---|---|---|---|---|---|---|
| Market cap | 3.48B | 3.06B | 6.60B | 1.50B | 5.41B | 2.26B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -9.0 | -7.5 | -67.9 | -38.5 | -24.8 | -7.9 |
| Price/book | 2.9 | 6.7 | 9.0 | 3.6 | 13.4 | 4.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +34.89% | +46.69% | +583.18% | −9.15% | +567.92% | +37.19% |
| Today | −0.14% | −0.29% | −0.41% | −1.19% | −3.56% | −2.05% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All IDYA news ›Idea Financial Closed on Their Inaugural $100M Asset-Backed Securitization
Idea Financial just closed its inaugural $100 million securitization. The technology-enabled lender offers term loans and lines of credit to small businesses. “…it’s a deeply personal moment because reaching this milestone for our company,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com2
-
debanked.com1
-
lw.com1
-
pharmaphorum.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.